查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1933369

全球貓疫苗市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考慮因素以及未來預測（2026-2034）

Feline Vaccines Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 167 Pages | 商品交期: 請詢問到貨日

價格

貓疫苗市場成長因素

預計2025年全球貓疫苗市場規模將達到16.7億美元，2026年將成長至17.6億美元，到2034年將達到32.1億美元，預測期內複合年增長率（CAGR）為7.83%。北美地區將在2025年佔42.77%的市場佔有率，這主要得益於貓咪飼養率的上升、先進的醫療保健基礎設施以及寵物主人預防保健意識的增強。貓疫苗可以保護貓咪免受貓泛白血球減少症、貓呼吸道疾病、貓杯狀病毒、皰疹病毒、狂犬病和貓白血病病毒（FeLV）等嚴重疾病的侵害。 這些疾病在全球日益普遍，加上獸醫服務和研究計畫的增加，正在推動市場擴張。

像碩騰服務有限公司 (Zoetis Services LLC)、默克公司 (Merck & Co., Inc.) 和禮來動保 (Elanco) 這樣的領先公司正專注於研發能夠提供更廣泛保護和更持久免疫力的創新疫苗，從而進一步加速市場成長。例如，一項在義大利坎帕尼亞地區（2019-2021 年）進行的研究發現，在接受檢測的 328 隻寵物貓中，73.5% 的貓貓泛白血球減少症病毒檢測呈陽性，這表明市場對積極的疫苗接種計劃有著很高的需求。

市場動態

成長因素：貓疫苗市場的成長主要受養貓家庭數量的增加和醫療需求的擴大所驅動。 根據美國寵物用品協會 (APPA) 2023-2024 年的報告，美國養貓家庭數量將達到 4,900 萬戶，佔所有寵物家庭的 37%。此外，狂犬病和貓白血病病毒 (FeLV) 等貓科疾病的日益流行，提高了寵物主人為貓咪接種疫苗的意願，從而推動了市場擴張。

限制因素：發展中地區獸醫服務資源有限是主要限制因素。例如，截至 2022 年，肯亞只有 410 名獸醫，這限制了疫苗的普及。

機會：政府主導的貓咪疫苗接種計劃提供了成長機會。 2025 年 7 月，印度納西克市政府啟動了流浪貓絕育和狂犬病疫苗接種計劃，這表明政府對預防人畜共患病傳播的支持力度正在加強。

挑戰：由於擔心安全性和副作用以及缺乏相關知識，寵物主人對疫苗接種猶豫不決，這阻礙了市場成長。美國獸醫協會 (AVMA) 在 2024 年 1 月報告稱，一些貓主人仍然不願意給寵物接種疫苗，這影響了疫苗接種率。

市場趨勢

貓科疾病疫苗平台的創新是關鍵趨勢。例如，默克公司在 2024 年 9 月擴展了其 NOBIVAC NXT 平台，使其能夠覆蓋貓白血病病毒 (FeLV)，從而提供更高級的保護。這項進展表明，人們正致力於研發高效、持久且安全的貓用疫苗。

市場區隔分析

依技術分類：

  • 滅活​​疫苗因其安全性高且政府支持的項目（尤其是狂犬病控制項目）佔主導地位。 2024年3月，默克公司根據 "狂犬病使命" 計畫捐贈了NOBIVAC狂犬病疫苗。
  • 減毒活疫苗越來越多地用於貓泛白血球減少症等疾病。
  • 例如，由於技術進步和貓科疾病日益普遍，重組疫苗預計將快速增長。

依疾病類型分類：

  • 受人畜共通傳染病風險的影響，狂犬病將在2024年佔最大佔有率。 根據美國獸醫協會 (AVMA) 的數據，2023 年美國共確診 222 例貓狂犬病病例。
  • 預計貓白血病病毒 (FeLV) 的發生率將顯著上升。智利的一項研究發現，182 隻寵物貓中有 54.9% 感染了 FeLV。
  • 貓病毒性鼻氣管炎和其他疾病的發生率正以中等速度增長。

依給藥途徑：

  • 由於其高效且起效迅速，注射疫苗越來越受歡迎。
  • 由於其給藥過程無壓力且免疫反應迅速，鼻腔疫苗越來越受歡迎。例如，禮來公司的貓用超強鼻腔疫苗 (Feline UltraNasal FVRCP) 可預防三種最常見的貓科疾病。

依分銷管道劃分：

  • 獸醫診所是主要市場，主要得益於宣傳活動和合作關係，例如 Virbac 與 WSAVA 於 2022 年 10 月達成的合作。
  • 得益於 Petco Lab 於 2025 年 3 月開展的免費疫苗接種活動等舉措，獸醫診所正呈現擴張跡象。
  • 藥局和其他通路也預計將穩定成長，因為它們能夠提供便利的疫苗接種途徑。

區域展望

  • 北美：預計到 2025 年，北美市場規模將達到 7.1 億美元，這主要得益於較高的貓咪飼養率和先進的獸醫服務。美國將佔該地區最大的市場佔有率。
  • 歐洲：預計歐洲市場將強勁成長，這主要得益於英國 1,080 萬隻寵物貓的數量（PDSA 2024）。
  • 亞太地區：由於公眾意識的提高和寵物貓數量的增加，預計將實現最高的複合年增長率。預計到2024年，澳洲將擁有490萬隻寵物貓。
  • 中東、非洲和拉丁美洲：由於政府主導的疫苗接種計劃（例如，將於2025年2月啟動的阿布達比動物福利倡議），預計將實現溫和成長。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 貓科疾病概述：依主要國家和地區劃分（2025 年）
  • 監理現況：依主要國家及地區劃分（2025 年）
  • 貓科疾病疫苗接種概述
  • 新科技應用：依主要公司劃分
  • 關鍵趨勢：併購、業務合作等等。

第五章 全球貓科動物疫苗市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依技術分類
    • 滅活​​疫苗
    • 減毒活疫苗
    • 重組疫苗
    • 其他
  • 市場分析、洞察與預測：依疾病類型分類
    • 貓咪病毒性鼻氣管炎
    • 狂犬病疫苗
    • 貓白血病病毒疫苗
    • 其他
  • 市場分析、洞察與預測：依給藥途徑分類
    • 腸外給藥
    • 鼻腔給藥
  • 市場分析、洞察與預測：依通路分類
    • 獸醫院
    • 獸醫診所
    • 藥局和藥局
    • 其他
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章 北美貓疫苗市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章 歐洲貓疫苗市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 德國
    • 美國王國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪的納維亞
    • 其他歐洲國家

第八章 亞太地區貓疫苗市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章 拉丁美洲貓疫苗市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

章節10：中東與非洲貓疫苗市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會 (GCC) 國家
    • 南非
    • 中東和非洲其他地區

第 11 章 競爭分析

  • 全球市佔率分析（2025）
  • 公司簡介
  • Elanco
  • Boehringer Ingelheim International GmbH
  • Virbac
  • Merck &Co., Inc.
  • Zoetis Services LLC
  • Ceva
  • Bioveta, a.s.
Product Code: FBI113898

Growth Factors of feline vaccines Market

The global feline vaccines market was valued at USD 1.67 billion in 2025 and is projected to grow to USD 1.76 billion in 2026, reaching USD 3.21 billion by 2034, reflecting a CAGR of 7.83% during the forecast period. North America dominated the market in 2025 with a 42.77% share, driven by rising cat ownership, advanced veterinary healthcare infrastructure, and awareness among pet owners regarding preventive care. Feline vaccines protect cats from serious illnesses such as feline panleukopenia, feline respiratory diseases, calicivirus, herpesvirus, rabies, and feline leukemia virus (FeLV). The increasing prevalence of these diseases globally, coupled with the growth of veterinary services and research initiatives, is propelling the market's expansion.

Key players such as Zoetis Services LLC, Merck & Co., Inc., and Elanco have been focusing on innovative vaccines offering broader protection and longer-lasting immunity, thus further accelerating market growth. For example, a study conducted in Campania, Italy (2019-2021) revealed that 73.5% of 328 domestic cats tested positive for feline panleukopenia virus, indicating high demand for active vaccination programs.

Market Dynamics

Drivers: The growth of the feline vaccines market is largely driven by rising cat ownership and the increasing demand for preventive healthcare. In 2023-2024, the American Pet Products Association reported 49 million U.S. households owning a cat, representing 37% of pet-owning households. Additionally, the rising prevalence of feline diseases like rabies and FeLV encourages owners to vaccinate their pets, fueling market expansion.

Restraints: Limited access to veterinary services in developing regions poses a significant restraint. For example, in Kenya, only 410 veterinarians were available in 2022, limiting vaccine adoption.

Opportunities: Government initiatives for feline vaccination present growth opportunities. In July 2025, Nashik Municipal Corporation (India) launched a program to sterilize and vaccinate stray cats against rabies, reflecting increasing institutional support to prevent zoonotic disease spread.

Challenges: Vaccine hesitancy among pet owners, due to concerns over safety, side effects, and awareness gaps, continues to challenge market growth. The AVMA reported in January 2024 that some cat owners remain reluctant to vaccinate their pets, impacting adoption rates.

Market Trends

Innovations in vaccine platforms for feline diseases are a key trend. For instance, in September 2024, Merck & Co., Inc. expanded its NOBIVAC NXT platform to include FeLV, offering advanced protection against feline leukemia virus. Such developments demonstrate a focus on high-efficacy, long-lasting, and safer vaccines for cats.

Segmentation Analysis

By Technology:

  • Inactivated vaccines dominate due to high safety profiles and government-supported programs, particularly against rabies. In March 2024, Merck donated NOBIVAC rabies vaccines under the Mission Rabies initiative.
  • Live attenuated vaccines are increasingly used for diseases like feline panleukopenia.
  • Recombinant vaccines and others are projected to grow rapidly due to technological advancements and rising prevalence of feline diseases.

By Disease Type:

  • Rabies held the largest share in 2024, driven by zoonotic risks. AVMA reported 222 rabies cases in cats in 2023.
  • Feline leukemia virus (FeLV) is expected to grow significantly; a survey in Chile reported FeLV prevalence of 54.9% among 182 domestic cats.
  • Feline viral rhinotracheitis and other diseases are growing at a moderate pace.

By Route of Administration:

  • Parenteral vaccines dominate due to higher efficacy and rapid onset.
  • Intranasal vaccines are expanding due to stress-free administration and quick immune response. For example, Elanco's Feline UltraNasal FVRCP vaccine protects against three major diseases in cats.

By Distribution Channel:

  • Veterinary hospitals dominate, driven by awareness campaigns and partnerships such as Virbac with WSAVA in October 2022.
  • Veterinary clinics are expanding with initiatives like Petco Love's free vaccination drive in March 2025.
  • Pharmacies and other channels are expected to grow steadily, offering convenient access to vaccines.

Regional Outlook

  • North America: Market valued at USD 0.71 billion in 2025, driven by high cat ownership and advanced veterinary services. The U.S. accounts for the largest regional share.
  • Europe: Strong growth expected, with 10.8 million pet cats in the U.K. (PDSA 2024).
  • Asia Pacific: Fastest CAGR anticipated due to rising awareness and increasing number of pet cats; Australia reported 4.9 million pet cats in 2024.
  • Latin America & Middle East & Africa: Moderate growth driven by government-led vaccination programs, such as Animal Welfare Abu Dhabi initiative in February 2025.

Competitive Landscape

The market is semi-consolidated with key players like Zoetis Services LLC, Merck & Co., Inc., Elanco, Virbac, Ceva, and Boehringer Ingelheim. These companies leverage product innovation, strategic partnerships, and global presence to strengthen market position. Recent developments include:

  • August 2025: Bioveta launched Biofel vaccines for cats and Biocan for dogs in Venezuela.
  • September 2024: Merck launched NOBIVAC NXT FeLV.
  • June 2024: Merck expanded NOBIVAC NXT Rabies portfolio in Canada.

Conclusion

The global feline vaccines market is projected to grow from USD 1.67 billion in 2025 to USD 1.76 billion in 2026, reaching USD 3.21 billion by 2034 at a CAGR of 7.83%. Growth is driven by rising cat ownership, awareness of preventive care, government initiatives, and advances in vaccine technology. North America dominates, while Asia Pacific exhibits the fastest growth. Despite challenges like limited access in developing countries and vaccine hesitancy, innovations in vaccine platforms, intranasal vaccines, and strategic expansions of major players are expected to sustain market growth throughout the forecast period.

Segmentation By Technology

  • Inactivated
  • Live Attenuated
  • Recombinant
  • Others

By Disease Type

  • Feline Viral Rhinotracheitis
  • Rabies
  • Feline Leukemia Virus
  • Others

By Route of Administration

  • Parenteral
  • Intranasal

By Distribution Channel

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores
  • Others

By Region

  • North America (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
    • U.S.
    • Canada
  • Europe (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Overview of Feline Diseases by Key Countries, By Key Countries/ Region, 2025
  • 4.2. Regulatory Scenario by Key Countries/ Region, 2025
  • 4.3. Overview of Vaccination for Feline Diseases
  • 4.4. New Technology Launches, By Key Players
  • 4.5. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)

5. Global Feline Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Technology
    • 5.1.1. Inactivated
    • 5.1.2. Live Attenuated
    • 5.1.3. Recombinant
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Disease Type
    • 5.2.1. Feline Viral Rhinotracheitis
    • 5.2.2. Rabies
    • 5.2.3. Feline Leukemia Virus
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 5.3.1. Parenteral
    • 5.3.2. Intranasal
  • 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.4.1. Veterinary Hospitals
    • 5.4.2. Veterinary Clinics
    • 5.4.3. Pharmacies & Drug Stores
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Feline Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Technology
    • 6.1.1. Inactivated
    • 6.1.2. Live Attenuated
    • 6.1.3. Recombinant
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Disease Type
    • 6.2.1. Feline Viral Rhinotracheitis
    • 6.2.2. Rabies
    • 6.2.3. Feline Leukemia Virus
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 6.3.1. Parenteral
    • 6.3.2. Intranasal
  • 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.4.1. Veterinary Hospitals
    • 6.4.2. Veterinary Clinics
    • 6.4.3. Pharmacies & Drug Stores
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Feline Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Technology
    • 7.1.1. Inactivated
    • 7.1.2. Live Attenuated
    • 7.1.3. Recombinant
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Disease Type
    • 7.2.1. Feline Viral Rhinotracheitis
    • 7.2.2. Rabies
    • 7.2.3. Feline Leukemia Virus
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 7.3.1. Parenteral
    • 7.3.2. Intranasal
  • 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.4.1. Veterinary Hospitals
    • 7.4.2. Veterinary Clinics
    • 7.4.3. Pharmacies & Drug Stores
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.5.1. Germany
    • 7.5.2. U.K.
    • 7.5.3. France
    • 7.5.4. Italy
    • 7.5.5. Spain
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Feline Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Technology
    • 8.1.1. Inactivated
    • 8.1.2. Live Attenuated
    • 8.1.3. Recombinant
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Disease Type
    • 8.2.1. Feline Viral Rhinotracheitis
    • 8.2.2. Rabies
    • 8.2.3. Feline Leukemia Virus
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 8.3.1. Parenteral
    • 8.3.2. Intranasal
  • 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.4.1. Veterinary Hospitals
    • 8.4.2. Veterinary Clinics
    • 8.4.3. Pharmacies & Drug Stores
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.5.1. China
    • 8.5.2. Japan
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Feline Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Technology
    • 9.1.1. Inactivated
    • 9.1.2. Live Attenuated
    • 9.1.3. Recombinant
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Disease Type
    • 9.2.1. Feline Viral Rhinotracheitis
    • 9.2.2. Rabies
    • 9.2.3. Feline Leukemia Virus
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 9.3.1. Parenteral
    • 9.3.2. Intranasal
  • 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.4.1. Veterinary Hospitals
    • 9.4.2. Veterinary Clinics
    • 9.4.3. Pharmacies & Drug Stores
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Feline Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Technology
    • 10.1.1. Inactivated
    • 10.1.2. Live Attenuated
    • 10.1.3. Recombinant
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Disease Type
    • 10.2.1. Feline Viral Rhinotracheitis
    • 10.2.2. Rabies
    • 10.2.3. Feline Leukemia Virus
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 10.3.1. Parenteral
    • 10.3.2. Intranasal
  • 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.4.1. Veterinary Hospitals
    • 10.4.2. Veterinary Clinics
    • 10.4.3. Pharmacies & Drug Stores
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles (Overview, Technology, SWOT analysis, Recent developments, strategies, financials (based on availability))
    • 11.2.1. Elanco
    • 11.2.2. Boehringer Ingelheim International GmbH
    • 11.2.3. Virbac
    • 11.2.4. Merck & Co., Inc.
    • 11.2.5. Zoetis Services LLC
    • 11.2.6. Ceva
    • 11.2.7. Bioveta, a.s.

List of Tables

  • Table 1: Global Feline Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 2: Global Feline Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2021-2034
  • Table 3: Global Feline Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 4: Global Feline Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 5: Global Feline Vaccines Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 6: North America Feline Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 7: North America Feline Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2021-2034
  • Table 8: North America Feline Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 9: North America Feline Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 10: North America Feline Vaccines Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 11: Europe Feline Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 12: Europe Feline Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2021-2034
  • Table 13: Europe Feline Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 14: Europe Feline Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 15: Europe Feline Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Asia Pacific Feline Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 17: Asia Pacific Feline Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2021-2034
  • Table 18: Asia Pacific Feline Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 19: Asia Pacific Feline Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 20: Asia Pacific Feline Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Latin America Feline Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 22: Latin America Feline Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2021-2034
  • Table 23: Latin America Feline Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 24: Latin America Feline Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 25: Latin America Feline Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 26: Middle East & Africa Feline Vaccines Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 27: Middle East & Africa Feline Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2021-2034
  • Table 28: Middle East & Africa Feline Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 29: Middle East & Africa Feline Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034

List of Figures

  • Figure 1: Global Feline Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Feline Vaccines Market Value Share (%), by Technology, 2025 & 2034
  • Figure 3: Global Feline Vaccines Market Value Share (%), by Disease Type, 2025 & 2034
  • Figure 4: Global Feline Vaccines Market Value Share (%), by Route of Administration, 2025 & 2034
  • Figure 5: Global Feline Vaccines Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 6: Global Feline Vaccines Market Value Share (%), by Region, 2025 & 2034
  • Figure 7: North America Feline Vaccines Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 8: North America Feline Vaccines Market Value Share (%), by Technology, 2025
  • Figure 9: North America Feline Vaccines Market Value (USD billion), by Disease Type, 2025 & 2034
  • Figure 10: North America Feline Vaccines Market Value Share (%), by Disease Type, 2025
  • Figure 11: North America Feline Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 12: North America Feline Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 13: North America Feline Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 14: North America Feline Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 15: North America Feline Vaccines Market Value (USD billion), By Country, 2025 & 2034
  • Figure 16: North America Feline Vaccines Market Value Share (%), By Country, 2025
  • Figure 17: Europe Feline Vaccines Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 18: Europe Feline Vaccines Market Value Share (%), by Technology, 2025
  • Figure 19: Europe Feline Vaccines Market Value (USD billion), by Disease Type, 2025 & 2034
  • Figure 20: Europe Feline Vaccines Market Value Share (%), by Disease Type, 2025
  • Figure 21: Europe Feline Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 22: Europe Feline Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 23: Europe Feline Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 24: Europe Feline Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 25: Europe Feline Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Feline Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Feline Vaccines Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 28: Asia Pacific Feline Vaccines Market Value Share (%), by Technology, 2025
  • Figure 29: Asia Pacific Feline Vaccines Market Value (USD billion), by Disease Type, 2025 & 2034
  • Figure 30: Asia Pacific Feline Vaccines Market Value Share (%), by Disease Type, 2025
  • Figure 31: Asia Pacific Feline Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 32: Asia Pacific Feline Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 33: Asia Pacific Feline Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 34: Asia Pacific Feline Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 35: Asia Pacific Feline Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Feline Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Feline Vaccines Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 38: Latin America Feline Vaccines Market Value Share (%), by Technology, 2025
  • Figure 39: Latin America Feline Vaccines Market Value (USD billion), by Disease Type, 2025 & 2034
  • Figure 40: Latin America Feline Vaccines Market Value Share (%), by Disease Type, 2025
  • Figure 41: Latin America Feline Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 42: Latin America Feline Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 43: Latin America Feline Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 44: Latin America Feline Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 45: Latin America Feline Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Feline Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Feline Vaccines Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 48: Middle East & Africa Feline Vaccines Market Value Share (%), by Technology, 2025
  • Figure 49: Middle East & Africa Feline Vaccines Market Value (USD billion), by Disease Type, 2025 & 2034
  • Figure 50: Middle East & Africa Feline Vaccines Market Value Share (%), by Disease Type, 2025
  • Figure 51: Middle East & Africa Feline Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 52: Middle East & Africa Feline Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 53: Middle East & Africa Feline Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 54: Middle East & Africa Feline Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 55: Middle East & Africa Feline Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Feline Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Feline Vaccines Market Share (%), By Company, 2025